You will own and grow a high-potential territory by developing strategic account plans to increase the adoption of sequencing platforms across academic, government, and biotech sectors. This involves leading complex sales cycles, managing pipelines, and building long-term partnerships with key scientific stakeholders.
Provide high-quality technical expertise, training, and scientific support for Oxford Nanopore products to customers. Collaborate with internal teams to assist with product installation, experimental design, data analysis, and workflow validation.
The Field Applications Scientist will partner with Sales to provide technical expertise, support commercial opportunities, and ensure customer success with ONT technologies. Responsibilities include delivering training, troubleshooting workflows, and building strong technical relationships within the assigned territory.
The Associate Director will identify and validate new market opportunities for sequencing technology across oncology and clinical genomics sectors. They will lead evidence-generation initiatives and build strategic partnerships to drive broader adoption and commercial growth.
The Account Executive will drive the adoption and growth of Oxford Nanopore sequencing platforms across academic, government, and clinical research organizations in Upstate New York. Responsibilities include managing complex sales cycles, executing strategic account plans, and building long-term partnerships with key scientific stakeholders.
The Inside Sales Account Manager will own the full sales cycle for inbound leads, from qualification to closing, while deepening relationships with existing customers. They will also collaborate with marketing and field teams to execute campaigns and drive product adoption within their assigned territory.
The Account Manager is responsible for driving sales growth and awareness of nanopore products through dealer networks and new customers in Japan. This includes implementing strategic business plans, managing key customer relationships, and delivering on commercial targets for specific sequencing systems.
